(Circulation. 2001;104:234.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Successful Ventricular Defibrillation by the Selective Sodium-Hydrogen Exchanger Isoform-1 Inhibitor Cariporide
From the Medical Service, Section of Critical Care Medicine, North Chicago VA Medical Center (R.J.G., I.M.A., E.H., J.D.K.), and Department of Medicine, Division of Critical Care Medicine, Finch University of Health Sciences/The Chicago Medical School (R.J.G.), North Chicago, Ill.
Correspondence to Raúl J. Gazmuri, MD, PhD, Medical Service (111F), North Chicago VA Medical Center, 3001 Green Bay Rd, North Chicago, IL 60064. E-mail raul.gazmuri{at}med.va.gov
Background—— Sodium-hydrogen exchanger isoform-1 (NHE-1) activation worsens functional myocardial abnormalities associated with ischemia and reperfusion. We hypothesize that these abnormalities may limit cardiac resuscitation from ventricular fibrillation (VF) and investigated whether NHE-1 inhibition with the benzoylguanidine derivative cariporide could improve resuscitability, postresuscitation myocardial function, and short-term survival in isolated heart and intact rat models of VF.
Methods and Results—— In the isolated rat heart, VF was induced for 25 minutes. Perfusion was interrupted for the initial 10 minutes and restarted at 10% of baseline flow for the remaining 15 minutes (simulating chest compression). Cariporide ameliorated ischemic contracture, prevented postresuscitation diastolic dysfunction, and favored earlier return of contractile function. In the intact rat, cariporide, injected into the right atrium before chest compression was started (after 6 minutes of untreated VF), prompted spontaneous defibrillation between minutes 7 and 9 of chest compression in 6 of 8 rats. In contrast, electrical defibrillation was required in each of 8 control rats after completion of a predetermined 16-minute interval of VF. After resuscitation, cariporide-treated rats had less ventricular ectopic activity and normalized their hemodynamic function faster. Electrical defibrillation was then timed in control rats to match the time when spontaneous defibrillation occurred in cariporide-treated rats. With comparable VF duration, postresuscitation hemodynamic dysfunction was ameliorated by cariporide, but only when more severe ischemia was modeled by prolongation of the interval of untreated VF from 6 to 10 minutes.
Conclusion—— NHE-1 inhibition may represent a novel and remarkably effective intervention for resuscitation from VF.
Key Words: cardiopulmonary resuscitation • fibrillation • ischemia • sodium-hydrogen antiporter • cariporide
This article has been cited by other articles:
 |
|
 |
|
  S. Wang, J. Radhakrishnan, I. M. Ayoub, J. D. Kolarova, D. M. Taglieri, and R. J. Gazmuri Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury J Appl Physiol, July 1, 2007; 103(1): 55 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Kolarova, I. M. Ayoub, and R. J. Gazmuri Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2904 - H2911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kolarova, Z. Yi, I. M. Ayoub, and R. J. Gazmuri Cariporide Potentiates the Effects of Epinephrine and Vasopressin by Nonvascular Mechanisms During Closed-Chest Resuscitation Chest, April 1, 2005; 127(4): 1327 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Stevens, M. Salik Jahania, R. M. Mentzer Jr, and R. D. Lasley Sodium-hydrogen exchange inhibition attenuates in vivo porcine myocardial stunning Ann. Thorac. Surg., February 1, 2004; 77(2): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Rabkin, S. E. Cabreriza, F. H. Cheema, A. A. Hill, L. J. Curtis, R. R. Sciacca, R. S. Mosca, and H. M. Spotnitz Cariporide is cardioprotective after iatrogenic ventricular fibrillation in the intact swine heart Ann. Thorac. Surg., October 1, 2003; 76(4): 1264 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Rabkin, S. E. Cabreriza, J. C. LaCorte, A. D. Weinberg, L. Coku, R. Walsh, R. Mosca, and H. M. Spotnitz Sodium-hydrogen exchange inhibition preserves ventricular function after ventricular fibrillation in the intact swine heart J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1499 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Ayoub, J. Kolarova, Z. Yi, A. Trevedi, H. Deshmukh, D. L. Lubell, M. R. Franz, F. A. Maldonado, and R. J. Gazmuri Sodium-Hydrogen Exchange Inhibition During Ventricular Fibrillation: Beneficial Effects on Ischemic Contracture, Action Potential Duration, Reperfusion Arrhythmias, Myocardial Function, and Resuscitability Circulation, April 8, 2003; 107(13): 1804 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-r. Wann, M. H. Weil, S. Sun, W. Tang, and T. Yu Cariporide for Pharmacologic Defibrillation After Prolonged Cardiac Arrest Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 161 - 169. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Shinagawa, H. Mitamura, S. Ogawa, and S. Nattel Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling Cardiovasc Res, May 1, 2002; 54(2): 438 - 446. [Abstract] [Full Text] [PDF]
|
|